Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 70
- Press releases
Cannatrol Brings Breakthrough Postharvest Cannabis Tech to Europe in Partnership With Paralab Green
Cannatrol, the creators of the only total dry, cure and store system for the cannabis industry, announced today an exclusive partnership with Paralab Green, Europe’s premier distributor of cannabis processing solutions, establishing distribution of the company’s patented Vaportrol® Technology throughout Europe.
- Adult-Use
New York Cannabis Control Board Approves 109 New Licenses and Eases Advertising Rules
New York’s Cannabis Control Board (CCB) yesterday approved 109 new licenses alongside long-awaited amendments to advertising, labelling and packaging rules.
- Uncategorized
Deutschland genehmigt den ersten Anbauverband, während ein Flickenteppich von Anträgen eintrudelt
Geschrieben von Ben Stevens und Alex Khourdaji Am 01. Juli begann die nächste Phase der Säule 1 des deutschen CanG-Projekts, in der die Staaten das Antragsverfahren für Anbauverbände eröffnen.
- Data & Analysis
Germany Approves First Cultivation Association as Patchwork of Applications Roll In
Written by Ben Stevens and Alex Khourdaji On July 01, the next phase of Pillar 1 of Germany’s CanG project got underway, seeing states open up the application process for cultivation associations.
- Uncategorized
New Tilray Study Shows Significant Pain and Sleep Improvements with Medical Cannabis in Seniors
Tilray’s medical cannabis division has today published a new scientific study showing significant improvements in pain, sleep and quality of life in patients over 50.
- Uncategorized
Cannabis Rescheduling Dealt Blow as House Committee Passes Bill Aimed at Blocking Progress
The landmark US cannabis rescheduling project was dealt a major blow this week, as a controversial spending bill aimed at blocking the bill was passed by a key House Committee.
- Uncategorized
Campaign to Overturn Federal Cannabis Prohibition Dismissed By District Court
A legal campaign to overturn the federal prohibition of cannabis has been dismissed by a US state court, ruling that only the Supreme Court could make such a decision.
- Press releases
Calls for More Industry Transparency as Medical Cannabis Producer Reveals High Yield
Leading UK medical cannabis producer Dalgety has, for the first time, revealed its impressive yield while calling for more industry transparency across the UK market.
- Press releases
Script Assist’s Advanced Technology to Power CB1 Medical’s Patient Services
Script Assist, a digital platform for medical cannabis prescribing, is excited to announce that CB1 Medical will be the first UK mainland clinic to go live with its Software as a Service (SaaS) platform in August.
- Markets & Stocks
Cannabis Investment Insights From Cannabis Europa, Ananda Stock Jumps on Pre-Clinical Results, & More from Cannovum
Cannabis Europa – insights from leading cannabis investors Last week saw European cannabis industry leaders flock to London to attend this year’s Cannabis Europa conference.
- Medical
UK GP’s Critical Role in Prescribing Medical Cannabis
Written for Business of Cannabis by Releaf. General Practitioners (GPs) are on the frontline of healthcare in the UK, and represent the primary touchpoint for patients hoping to get treatment.
- Press releases
Organigram Invests in Sanity Group, a Leading German Cannabis Company
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce its first significant strategic investment aimed at expanding its presence in the European cannabis market.









